HIV-1 Nef triggers down-regulation of cell-surface MHC-I by assembling a Src family kinase (SFK)-
INTRODUCTION
After infection by HIV-1, the acute viremia induces an immune response that includes the development of anti-HIV CD8 ϩ cytotoxic T lymphocytes (CTLs) (Gandhi and Walker, 2002) . Though a significant number of the circulating CTL population is directed against HIV-1-infected cells, the virus escapes the adaptive immune response, establishing reservoirs in numerous cell types that can resist highly active antiretroviral therapy (HAART) (Stevenson, 2003) . During disease progression, the HIV-1 viral load increases greatly, destroying most of the CD4 ϩ lymphocytes, leaving patients increasingly susceptible to opportunistic infections (Douek et al., 2003) .
The adaptive immune response requires members of the class I major histocompatibility complex (MHC-I) to present viral antigens on the surface of infected cells, which destroys the infected cell by the cytolytic, apoptosis-inducing actions of CTLs (Lieberman, 2003) . Large DNA viruses, including herpesviruses and poxviruses, possess a large collection of immune evasive genes that are expressed in a coordinated manner to target nearly every step in the biosynthesis, assembly, transport, and cell-surface localization of MHC-I molecules (Yewdell and Hill, 2002; Peterlin and Trono, 2003) . By contrast, HIV-1 relies on the single 27-kDa N-myristoylated early gene product Nef to down-regulate MHC-I (Peterlin and Trono, 2003) . Nef is required for the onset of AIDS and can affect cells in many ways, including alteration of T-cell activation and maturation, subversion of the apoptotic machinery, and the down-regulation of cell-surface molecules, notably CD4 and MHC-I (Fackler and Baur, 2002) . Down-regulation of CD4 through the clathrin/AP-2 pathway to lysosomes eliminates interference of the viral receptor with HIV-1 envelopment or release. Down-regula-tion of cell-surface MHC-I molecules encoded by the HLA-A and -B loci to paranuclear TGN/endosomal compartments mediates the ability of HIV-1 to evade the CD8 ϩ immune surveillance system (Blagoveshchenskaya et al., 2002; Tomiyama et al., 2002; Yang et al., 2002; Peterlin and Trono, 2003) .
Two models-here referred to as the "signaling" and "stoichiometric" down-regulation pathways-are currently used to explain the molecular basis of Nef-mediated MHC-I down-regulation (see Hung et al., 2007) . The "signaling" model describes the sequential roles of three conserved Nef sites in mediating MHC-I down-regulation. The pathway is initiated by the EEEE 65 -dependent binding to the sorting protein PACS-2, which targets Nef to the paranuclear region, enabling PXXP 75 to bind and activate a Golgi region-localized Src Family Kinase (SFK). This Nef-SFK complex then phosphorylates ZAP-70 (Syk in monocytes and heterologous cells), forming a phosphotyrosine-based docking motif that recruits class I PI3K by ligating the p85 regulatory subunit C-terminal SH2 domain. This multikinase complex then triggers internalization of cell-surface MHC-I through a clathrin-independent, ARF6-dependent pathway (Blagoveshchenskaya et al., 2002; Hung et al., 2007; Atkins et al., 2008) . After internalization, Nef M 20 , located within an amphipathic ␣-helix, mediates the sequestering of endocytosed MHC-I molecules into paranuclear compartments (Blagoveshchenskaya et al., 2002; Hung et al., 2007; Chaudhry et al., 2008) . By contrast, the "stoichiometric" model envisions that Nef mediates MHC-I down-regulation by acting solely via a PI3K-independent pathway that diverts newly synthesized MHC-I molecules to degradative compartments by an M 20 -and AP-1-dependent mechanism (Kasper and Collins, 2003; Roeth et al., 2004; Kasper et al., 2005) . However, an alternative interpretation of the stoichiometric model suggests Nef binds endocytosed MHC-I but the underlying mechanism was not described (Roeth et al., 2004; Noviello et al., 2008) . While the stoichiometric model suggests the importance of Nef M 20 in mediating MHC-I down-regulation-a finding consistent with both models-it fails to address the roles of EEEE 65 and the PXXP 75 site within the polyproline helix.
The binding of HIV-1 Nef to the SH3 domains of SFKs requires PXXP 75 and an adjacent hydrophobic pocket, which anchors the SFK on Nef (Lee et al., 1995) . The determination that Nef can bind and directly activate a subset of SFKs together with the conservation of the SH3 domain binding site across various Nef alleles (Choi and Smithgall, 2004; Trible et al., 2006) suggests the Nef-SFK interaction is required for disease progression, including AIDS-like disease in animal models and assembly of the SFK-ZAP-70/Syk-PI3K multi-kinase complex, which triggers MHC-I downregulation in primary CD4
ϩ T-cells and promonocytic cells (Hanna et al., 1998; Hung et al., 2007) . These findings suggest that targeting the assembly of the multi-kinase complex may represent an attractive approach to inhibiting AIDS progression. The ability of isoform-specific class I PI3K kinase inhibitors to repress Nef-induced MHC-I down-regulation in primary CD4
ϩ T-cells supports this possibility (Hung et al., 2007; Atkins et al., 2008) . Alternatively, small molecule inhibitors that disrupt the binding of Nef to one or more of the kinases that form the multi-kinase complex would inhibit Nef action without disrupting the activity of cellular kinases that may be required for host cell function.
Here we report that small molecule disruption of Nef-SFK binding represses MHC-I down-regulation in HIV-1-infected primary CD4 ϩ T-cells by interfering with formation of the multi-kinase complex. We further show that Nefinduced MHC-I down-regulation in primary CD4
ϩ T-cells is manifest by the sequential action of the signaling mode, which lasts for more than two days after infection, followed by the stoichiometric mode by three days postinfection.
Interference with the multi-kinase complex that triggers the signaling mode disrupts the subsequent stoichiometric block in MHC-I transport, suggesting the two modes are causally linked. These studies challenge the current dogma of Nef-mediated MHC-I down-regulation (Hansen and Bouvier, 2009 ) and suggest Nef orchestrates a highly regulated molecular program consisting of the sequential use of signaling followed by stoichiometric modes to evade immune surveillance.
MATERIALS AND METHODS

Cells, Viruses, and Plasmids
293T, A7, BSC-40, HeLa-CD4 ϩ , H9 CD4 ϩ T-cells, and CEM T-cells were cultured as described (Hung et al., 2007) . Peripheral blood was obtained from healthy HLA-A*0201 ϩ volunteers by leukapheresis or venipuncture using protocols approved by the OHSU Institutional Review Board (protocols IRB00004039 and IRB00002251) or by the International Medical Center of Japan and the Kumamoto University Ethical Committee. Primary human CD4
ϩ T-cells were isolated as described (Hung et al., 2007) and cultured in RPMI 1640 containing 10% FBS and supplemented with IL-2 (50 U/ml; Sigma) and 1 g/ml PHA (Sigma, St. Louis, MO) before infection. HIV-1 , vaccinia virus (VV), and vaccinia recombinants expressing FLAG-tagged Nef (Nef/f, C-terminal epitope tag), Nef AXXA /f, Nef AXXA -PI3K*, Hck, Src, or ZAP-70, and HIV pseudotyped viruses NL4-3⌬G/P-EGFP (titer ϭ 4.5 ϫ 10 7 IFU/ml) and NL4-3⌬G/P-EGFP/⌬Nef (titer ϭ 2.1 ϫ 10 7 IFU/ml) were grown and titered by marker expression as described (Blagoveshchenskaya et al., 2002; Hung et al., 2007) . Adenoviruses expressing HA-tagged PACS-1 or PACS-2 were described previously (Blagoveshchenskaya et al., 2002; Simmen et al., 2005) . Nef-eYFP, Nef AXXA -eYFP and pPTEN were previously described (Hung et al., 2007) and pmaxGFP was obtained from Dharmacon (Boulder, CO).
Inhibitors, siRNAs, qRT-PCR, and Kinase Assays
PI-103 (Calbiochem, San Diego, CA) and 2c (2,4-dihydroxy-5-(1-methoxy-2-methylpropyl)benzene-1,3-dialdehyde, (Kyowa Hakko Kirin Co., Tokyo, Japan) were used as indicated. 2c toxicity was determined by MTT (Invitrogen, Carlsbad, CA) according to manufacturer's instructions. Control (nonspecific) siRNA and siRNAs specific for Hck, Lyn, Src, PACS-1, PACS-2, or the 1A subunit of AP-1 (Smartpool, Dharmacon) were nucleofected (Amaxa, Gaithersburg, MD) into cells according to manufacturer's instructions. RNA was purified from H9 cells nucleofected with siRNAs as indicated in figure legends using the RNeasy kit (Qiagen, Valencia, CA) according to manufacturer's instructions. cDNA was reverse transcribed from RNA using the random decamers from the RETROscript Kit (Ambion, Austin, TX) via manufacturer's instructions. Utilizing commercially-available Hck, Lyn, and Src primers (Qiagen) and SYBR green qPCR reagent (SA-Biosciences, Frederick, MD), q-PCR was conducted on a StepOnePlus Real-time PCR system (Applied Biosciences, Foster City, CA). PI3K assays were performed as described (Atkins et al., 2008) . In vitro Hck kinase assays were performed as described (Emert-Sedlak et al., 2009) .
Flow Cytometry and Immunofluorescence Microscopy
For flow cytometry, cells were processed as described (Hung et al., 2007; Atkins et al., 2008) and stained using the following antibodies: anti-MHC-I (W6/32), anti-HLA-A2 (BB7.2, BD, San Jose, CA), anti-CD4-APC (Biolegend, San Diego, CA), or anti-p24-FITC (Virostat, Portland, ME) as indicated in legends. PE-conjugated donkey anti-mouse IgG (Jackson IR, West Grove, PA) was used to stain MHC-I-and HLA-A2-positive cells. Isotype-matched antibodies (Serotec, Raleigh, NC) were used as negative controls. Samples were processed on a FACSCalibur (BD) as described (Atkins et al., 2008) and data analyzed using FCS express (De Novo Software, Los Angeles, CA). For immunofluorescence microscopy, cells were processed as indicated in legends and processed for immunofluorescence as described (Atkins et al., 2008) . Confocal images were captured as described (Atkins et al., 2008) and colocalization of Nef-eYFP with Golgin-97 was quantified morphometrically using Imaris 7.0. A mask for each field of cells was generated based on the fluorescent signal of Golgin-97 and the percent colocalization of Golgin-97 with Nef-eYFP was determined and presented as the mean Ϯ SD from at least 20 cells per condition. (Atkins et al., 2008) . Antibody uptake using mAb W6/32 was performed as described (Blagoveshchenskaya et al., 2002) . (Bodenhausen and Ruben, 1980) were performed at 27°C on a Bruker Avance 700 MHz spectrometer equipped with a 5-mm, triple resonance, and z-axis gradient cryoprobe. The N HSQC spectra were also obtained after adding the same amounts of DMSO without 2c to the free Nef sample. In this series, in contrast to the titration with the 2c solution, minimal spectral changes occurred (data not shown), confirming that the changes after addition of 2c were indeed caused by this organic molecule and not the solvent.
NMR Spectroscopy
Transport Assay and Endo H Treatment
H9 cells were infected with Nef
Ϫ or Nef ϩ pseudotyped HIV-1 NL4-3 viruses for 24, 48, or 72 h. After infection, cells were subjected to pulse-chase/surface biotinylation as described (Blagoveshchenskaya et al., 2002) . Briefly, to IP with HC10, cells were lysed in m-RIPA [1% NP-40, 1% sodium deoxycholate, 150 mM NaCl, 50 mM Tris-HCl (pH 8.0)] and then heated for 1 h at 55°C to denature MHC-I proteins. To IP with BB7.2, cells were lysed in PBS (pH 7.2) containing 1% NP-40. Bound MHC-I proteins were eluted from protein A sepharose beads (Sigma) by boiling in TBS, 5% SDS, 2% NP-40, and 2% sodium deoxycholate. One-third of the eluate was used to assess total MHC-I while the rest was incubated with streptavidin agarose (Pierce, Rockford, IL) to capture biotinylated MHC-I. For Endo H treatment, MHC-I was eluted by boiling in 10 mM Tris-HCl (pH 7.4) containing 1% SDS, precipitated with acetone and resuspended in glycoprotein denaturation buffer (NEB, Ipswich, MA) and digested with 10 U of Endoglycosidase H for 1 h at 37°C. Samples were separated by SDS-PAGE and processed using Amplify (GE Healthcare). Quantification was performed using NIH Image J.
Protein Interaction Assays
Plasmids expressing GST, GST-MHC-I CDNef LL/AA (provided by J. Guatelli, UCSD), His 6 -HcK∧OR GST-Nef (strain NL4-3), were transformed in BL21 E. coli and cultures were induced with 1 mM IPTG (Calbiochem) for 4 h at 37°C. Bacterial pellets were resuspended in lysis buffer [50 mM Tris (pH 7.6), 1.5 mM EDTA, 100 mM NaCl, 0.5% Triton X-100, 0.1 mM DTT, 10 mM MgCl 2 ] containing protease inhibitors (0.5 mM PMSF and 0.1 M each of aprotinin, E-64, and leupeptin), lysed using a French Press (Aminco, Rockville, MD) and incubated with GST-sepharose (GE Healthcare). For the interaction with GST-MHC-I CDNef LL/AA , A7 cells were lysed in 50 mM Tris-HCl (pH 8.0), 1% Triton X-100, 5 mM EDTA, 150 mM NaCl, 10 mM MgCl 2 with protease inhibitors (0.5 mM PMSF and 0.1 M each of aprotinin, E-64, and leupeptin). A7 lysates were added to GST-Sepharose bound to the proteins of interest overnight at 4°C. The resin was incubated or not with 20 M 2c for one hour, washed three times in lysis buffer and once in 50 mM Tris (pH 8.0), and resuspended in SDS-PAGE sample buffer. For the His 6 -Hck interaction with GST-Nef, the proteins were mixed at a 2:1 ratio (Hck:Nef) for 30 min at 4°C in binding buffer [0.1% NP-40, 0.1 mM EDTA, 20 mM Tris (pH 7.9), 150 mM NaCl] containing the indicated concentrations of 2c. After incubation, GSTSepharose was added and subsequently washed three times in binding buffer and resuspended in SDS-PAGE sample buffer.
RESULTS
HIV-1 Nef Uses a Subset of SFKs to Trigger MHC-I Down-Regulation
Formation of the SFK-ZAP70/Syk-PI3K multi-kinase complex is initiated by the PXXP 75 -dependent binding of Nef to the SH3 domain of a Golgi region-localized SFK, directly activating the kinase (Hung et al., 2007) . Of the seven known SFKs only a subset-Hck, Lyn, and Src-can be directly activated after Nef binding and are found in the Golgi region, suggesting one or more of these kinases mediate MHC-I down-regulation (Matsuda et al., 2006; Trible et al., 2006; Hiyoshi et al., 2008; Pulvirenti et al., 2008) . To test this, H9 CD4
ϩ T-cells treated with siRNAs specific for Hck, Lyn, or Src ( Figure 1A and supplemental Figure S1 ) were infected with recombinant viruses expressing Nef and the extent of MHC-I down-regulation was determined. Nefinduced MHC-I down-regulation was slightly repressed by siRNA knockdown of Hck alone but blocked by knockdown of Hck, Lyn, and Src together. The data suggest that Hck, Lyn, and Src function redundantly in Nef-induced MHC-I down-regulation.
Small Molecule Inhibition of the Nef-SFK Interaction
The determination that Nef assembles a multi-kinase complex to trigger MHC-I down-regulation suggests this pathway can be selectively targeted pharmacologically. Indeed, isoform-specific class I PI3K inhibitors repress Nef-induced MHC-I down-regulation in primary CD4
ϩ T-cells (Hung et al., 2007; Atkins et al., 2008 ). An alternative approach would be to block protein-protein interactions required for complex assembly without affecting cellular enzyme activity directly. The characterized binding of Nef to SFK SH3 domains represents an ideal target for this type of inhibitor (Arold et al., 1997) . One candidate compound, 2c (supplemental Figure  S2) , is a derivative of the compound UCS15A that disrupts the PXXP-dependent binding of Sam68 to Src (Oneyama et al., 2003) . To test whether 2c disrupts Nef-SFK binding, we treated H9 CD4 ϩ T-cells coexpressing flag-tagged Nef (Nef/f) and Hck with increasing concentrations of 2c. Hck was used because it binds Nef with higher affinity than other SFKs and Nef can assemble Hck into the multi-kinase complex (Hung et al., 2007; Atkins et al., 2008) . Coimmunoprecipitation analysis showed 2c repressed the interaction between Nef and Hck in a dose-dependent manner as well as repressed the interaction with Lyn or Src ( Figure 1B and supplemental Figure S3 ). Next, we incubated GST-Nef and His 6 -Hck with increasing concentrations of 2c and found that 2c disrupted Nef-Hck binding in a dose-dependent manner ( Figure 1C ). To determine whether the ability of 2c to inhibit Nef-SFK binding also blocked Nef-induced SFK activation, we incubated recombinant, purified Nef, and Hck with increasing concentrations of 2c and measured the resulting Nef-induced Hck activity using a FRET-based in vitro kinase assay. Under these assay conditions, activation of Hck is dependent upon Nef (Emert-Sedlak et al., 2009) . As shown in Figure 1D , 25 M 2c substantially repressed Nefdependent Hck activity without affecting Hck in the absence of Nef. High 2c concentrations (Ն100 M), however, directly inhibited Hck activity. These findings suggest 2c has a bimodal effect on Hck activity; at low concentrations 2c disrupts Nef-induced kinase activity, whereas high concentrations of 2c inhibit Hck directly.
The ability of 2c to selectively inhibit Nef-induced Hck activation suggested 2c may bind Nef directly, thereby affecting Hck activity. Accordingly, ϩ T-cells were nucleofected (Amaxa) on days 1 and 3 with pmaxGFP and nonspecific siRNA or siRNAs that target Hck, Lyn, or Src alone or in combination. On day 4 cells were infected with VV:WT (gray filled) or VV:Nef (lines, unfilled) (moi ϭ 10, 8 h), and analyzed by flow cytometry using mAb W6/32 as described in experimental procedures. MFI: NS siRNA (WT ϭ 167, Nef ϭ 99.5); Nef ϩ Hck siRNA ϭ 120; ϩ Lyn siRNA ϭ 103; ϩ Src siRNA ϭ 117; ϩ Hck, Lyn, Src ϭ 169. MFI, mean fluorescence intensity. (B) H9 cells were coinfected with VV:WT, VV:Nef/f or Nef AXXA /f (moi ϭ 10, 8 h) and VV:Hck (moi ϭ 2, 8 h) and treated with 10, 20, or 50 M 2c for 4 h before harvest. Nef/f proteins were immunoprecipitated, and coprecipitating Hck was detected by Western blot. (C) GST-Nef was incubated with His 6 -Hck and treated with increasing concentrations of 2c. GST-Nef was captured, and bound His 6 -Hck was quantified using NIH Image J. Accordingly, nonspecific binding of GST to His 6 -Hck was subtracted and values were normalized to the binding of GST-Nef to His 6 -Hck in the absence of 2c. Each condition was assayed in triplicate, and results are presented as the mean Ϯ SD. (D) Hck alone (gray bars) or Hck plus Nef (black bars) were treated with increasing concentrations of 2c. The resulting Hck enzyme activity was measured using a fluorometric assay and expressed relative to 100% control activity. Each condition was assayed in quadruplicate and results are presented as the mean Ϯ SD. Figure 1E ). These include relatively small chemical shift changes (0.025-0.063ppm) at V 74 , M 79 , and T 80 located within the Nef polyproline helix that binds the RT loop of SH3 domains on SFKs (Lee et al., 1995) , suggesting 2c may influence the conformation of the polyproline helix. The presence of resonance overlap in the NMR spectra precluded more detailed analysis involving the disordered regions of Nef such as the N-terminal region preceding the polyproline helix and the internal loop consisting of residues E 149 -K 178 . More pronounced chemical shift changes (Ͼ0.1ppm) were observed for the resonances of Y 135 , K 144 , V 146 , K 184 (R 184 in Figure 1F [PDB ID:2NEF]), F 185 , and L 189 which are clustered on the opposite side of the SH3 domain binding site. Other residues in this region such as V 148 , A 190 , F 191 , M 194 , and E 197 , and L 198 also undergo substantial (Ͼ0.06ppm) changes. These chemical shift perturbations caused by the addition of 2c imply that 2c could bind to the cleft formed by the central ␤-sheet and the Cterminal ␣-helices of Nef, which may provide a good binding pocket ( Figure 1F ). Together, these findings suggest 2c may interfere with Nef-induced SFK activation most likely by allosteric inhibition of SFK binding or possibly by directly influencing the binding mode of the polyproline helix to SFKs or both.
2c Represses the Ability of HIV-1 to Down-Regulate MHC-I The 2c concentration range that selectively inhibited Nefdependent SFK activation showed no measurable cell toxicity up to 60 M for two days, suggesting 2c could be tested in culture ( Figure S4, panel A) . Accordingly, we treated H9 cells expressing Nef-eYFP with 2c or the class I PI3K inhibitor PI-103, which specifically blocks Nef-induced MHC-I down-regulation (Hung et al., 2007) , and measured cellsurface MHC-I (Figure 2A ). In agreement with earlier studies (Hung et al., 2007; Atkins et al., 2008) , Nef-eYFP induced an ϳtwofold down-regulation of MHC-I that was blocked by PI-103. Similarly, 2c partially blocked MHC-I down-regulation. Next, we asked whether 2c could interfere with HIV-1-induced MHC-I down-regulation in primary CD4 ϩ T-cells. We infected primary CD4
ϩ T-cells with HIV-1 and treated the cultures with vehicle or 2c. At 8 d postinfection, the cells were analyzed for cell-surface HLA-A2 and CD4 by flow cytometry ( Figure 2B ). We found that 2c partially blocked down-regulation of MHC-I but had no effect on down-regulation of CD4, which is mediated by a class I PI3K-independent pathway (Hung et al., 2007) .
2c Disrupts Formation of the Multi-Kinase Complex
The ability of 2c to disrupt Nef-SFK binding as well as HIV-1-induced MHC-I down-regulation suggested this compound would disrupt assembly of the SFK-ZAP-70-PI3K multi-kinase complex. Accordingly, we found that 2c blocked the ability of Nef to recruit class I PI3K activity using an in vitro lipid kinase assay ( Figure 3A) . Moreover, this result was not due to cell toxicity or induction of apoptosis nor was it due to nonspecific inhibition of class I PI3K as treatment of the immunoprecipitate with 40 M 2c had no effect on enzyme activity (supplemental Figure  S4 , B and C and Figure 3A) . The titration analysis of 2c on Nef-induced Hck activation ( Figure 1D ) suggests 40 M 2c blocked Nef-induced PI3K stimulation by selective inhibition of Nef-induced SFK activation, whereas 100 M 2c may block Nef-induced PI3K stimulation by additionally inhibiting SFK activation directly. The PI3K activity results were supported by coimmunoprecipitation analysis in which 2c inhibited formation of the multi-kinase complex by disrupting the interaction of Nef with Hck, phospho-ZAP-70 and the class I PI3K p85 regulatory subunit ( Figure 3B ). The ability of 2c to disrupt Nef-SFK binding did not exclude the possibility that it may affect additional steps in the MHC-I down-regulation pathway. We first asked whether 2c interfered with steps upstream of Nef-SFK binding. Accordingly, we found that 2c had no effect on the Nef-PACS-2 interaction nor the PACS-2-dependent trafficking of Nef-eYFP to the paranuclear region, which is required for Nef-SFK binding and Nef-induced MHC-I down-regulation (Figure 3, C and D and Atkins et al., 2008) .
Because Nef M 20 mediates the interaction with AP-1 (Roeth et al., 2004) and is essential for sequestration of MHC-I molecules after their internalization from the cell surface (Blagoveshchenskaya et al., 2002) , we tested whether AP-1 was required in the last stage of this signaling pathway. Accordingly, H9 cells knocked down for AP-1A, PACS-2, or PACS-1 which is required for MHC-I down-regulation but not for triggering PI3K stimulation (Piguet et al., 2000; Atkins et al., 2008) , were infected with viruses expressing Nef or the Nef AXXA -PI3K* chimera, which rescues the inability of Nef AXXA to down-regulate MHC-I by overriding the requirement for assembly of the SFK-ZAP-70-PI3K complex (supplemental Figure S5 and Blagoveshchenskaya et al., 2002; Hung et al., 2007) . The ability of Nef or Nef AXXA -PI3K* to down-regulate MHC-I in cells knocked down for expression of PACS-2, PACS-1, or AP-1A was assessed by antibody uptake to discern the importance of each protein in steps upstream or downstream of PI3K stimulation ( Figure 4A ). Consistent with our determination that Nef requires PACS-2 upstream of PI3K (Atkins et al., 2008) , siRNA knockdown of PACS-2 blocked MHC-I uptake by Nef but not by Nef AXXA -PI3K*. By contrast, siRNA knockdown of AP-1A or PACS-1 blocked MHC-I uptake induced by Nef and Nef AXXA -PI3K*, demonstrating AP-1 and PACS-1 act downstream of PI3K stimulation.
To test potential effects of 2c on the later stages of this pathway, we asked whether 2c interfered with the interaction between Nef and PACS-1 or AP-1. We determined that 2c had no effect on the Nef-PACS-1 interaction (Figure 4B) . Additionally, the interaction of AP-1 with Nef M 20 and the MHC-I cytosolic domain can be recapitulated using the chimeric protein GST-MHC-I CD-Nef LL/AA to capture AP-1 from cytosol preparations (Noviello et al., 2008) . This chimera consists of Nef with an LL 165 3 AA substitution, which blocks the LL 165 -dependent binding to adaptors, fused to the MHC-I cytosolic domain. We found that 2c did not interfere with the ability of GST-MHC-I CD-Nef LL/AA to capture AP-1 (Figure 4C, left) . Interest- (Grzesiek et al., 1997) ingly, we found that GST-MHC-I CD-Nef LL/AA captured PACS-1 but not PACS-2, consistent with our determination that Nef requires PACS-1 subsequent to PI3K stimulation to down-regulate MHC-I ( Figure 4C , right). Moreover, similar to our findings with AP-1, 2c failed to disrupt the interaction of GST-MHC-I CD-Nef LL/AA with PACS-1. To further evaluate whether 2c disrupts MHC-I down-regulation downstream of PI3K stimulation, we repeated the antibody uptake experiment ( Figure 4D ). We found that 2c blocked the ability of Nef but not Nef AXXA -PI3K* to down-regulate MHC-I, indicating 2c specifically acts upstream of PI3K stimulation.
PTEN-Null CEM Cells Fail to Phenocopy Nef Action in Primary CD4
؉ or H9 Cells Our results using primary CD4 ϩ T-cells and H9 cells suggest 2c disrupts HIV-1-mediated MHC-I down-regulation by interfering with the ability of Nef to assemble the SFK-ZAP-70/Syk-PI3K complex. This signaling pathway explains the importance of the EEEE 65 and PXXP 75 sites, which trigger MHC-I internalization and subsequent M 20 -mediated sequestering of internalized MHC-I molecules (Blagoveshchenskaya et al., 2002; Hung et al., 2007) . However, an alternate model of MHC-I down-regulation, which largely relies on CEM T-cells stably expressing MHC-I, envisions a PI3K-independent pathway based largely on the M 20 -mediated stoichiometric block of newly synthesized MHC-I molecules en route to the cell surface (Kasper and Collins, 2003) . We therefore transfected CEM cells with plasmids expressing PTEN alone or together with Nef ( Figure 5A ), and tested whether 2c or PI-103 would repress MHC-I down-regulation. Because transfected PTEN can be inhibited by oxidation in leukemic cells, these experiments were conducted in 0.5 mM ␤-mercaptoethanol (Silva et al., 2008) . In contrast to H9 cells or primary CD4
ϩ T-cells, both compounds failed to repress MHC-I down-regulation in CEM cells ( Figure 5B , top), suggesting Nef may down-regulate MHC-I in CEM cells by a mechanism different from it uses in H9 or primary CD4 ϩ T-cells. Alternatively, the disparate findings may have resulted from the dysregulated PI3K signaling inherent to CEM cells, which would override the requirement for the multi-kinase complex (Astoul et al., 2001) . Indeed, many leukemic cell lines such as CEM and Jurkat lack the tumor suppressor PTEN, which is a lipid phosphatase that attenuates PI3K signaling by dephosphorylating PIP 3 . Thus, loss of PTEN results in constitutively elevated levels of PI3K/Akt signaling characteristic of many tumor cell lines. Although acute treatment of CEM or Jurkat cells with PI3K inhibitors prevents new PIP 3 synthesis, the absence of PTEN results in persistently elevated levels of PIP 3 that mediate PI3K-stimulated pathways even in the presence of PI3K inhibitors, thereby conferring resistance to the effect of multi-kinase complex inhibition (Hung et al., 2007) . We therefore expressed PTEN alone or PTEN together with Nef ( Figure 5A) and determined that PTEN alone had little effect on the cell-surface levels of endogenous MHC-I, which is expected because this enzyme is normally expressed in CD4 ϩ T-cells ( Figure 5B, bottom) . Reexpression of PTEN, however, repressed the constitutively elevated PI3K/Akt signaling present in CEM cells as determined by a decrease in active (phosphorylated) Akt (Figure 5A ), suggesting that PTENreplete CEM cells may be rescued in their ability to regulate PIP 3 levels and would thus be responsive to treatment with PI3K inhibitors. Accordingly, reexpression of PTEN rescued the ability of PI-103 or 2c to repress MHC-I down-regulation in CEM cells, similar to that observed in primary CD4 ϩ T-cells or H9 cells ( Figure 5B bottom and see Figure 2 ). These results demonstrate that an intact PI3K regulatory network is required to study PI3K-dependent steps in signaling pathways, including Nef-induced MHC-I down-regulation.
Nef Down-Regulates MHC-I by a PI3K-Triggered Endocytic Pathway Followed by a Transport Block
Whereas aberrant phosphoinositide metabolism in CEM cells can explain the confusion underlying the requirement by Nef for the multi-kinase complex to down-regulate MHC-I (Kasper and Collins, 2003; Schaefer et al., 2008) , this defect did not readily explain why some studies found that Nef blocks delivery of newly synthesized MHC-I molecules en route to the cell surface-the stoichiometric modelwhereas other studies found Nef relies on its ability to assemble the multi-kinase complex to internalize and sequester MHC-I molecules following their delivery to the cell surface-the signaling model. Although these disparate findings were originally attributed to uncharacterized differences in Golgi-to-cell-surface transport in T-cells versus HeLa cells (Kasper and Collins, 2003) , closer inspection of the experimental paradigm revealed that the signaling model assessed MHC-I transport at 7-44 h postinfection while the stoichiometric model assessed ER-to-cell surface transport of MHC-I at longer postinfection times (Blagoveshchenskaya et al., 2002; Kasper et al., 2005; Hung et al., 2007) . We therefore conducted a time course to measure the ability of Nef to impede cell surface delivery of newly synthesized endogenous MHC-I molecules ( Figure 6A ). Parallel cultures of H9 cells infected for 24, 48, or 72 h with pseudotyped HIV-1 NL4-3 that either lack or express Nef were subjected to pulse-chase/surface biotinylation to monitor delivery of MHC-I to the cell surface. At 24 and 48 h postinfection, Nef had no measurable effect on the transport of newly synthesized MHC-I to the cell-surface. By 72 h postinfection, however, Nef markedly repressed MHC-I transport. To test whether these results were specific to H9 cells or the use of HC10, which recognizes denatured HLA-B and C heavy chains, we repeated the pulse-chase/surface biotinylation in primary CD4
ϩ T-cells using the conformation dependent antibody, BB7.2, which recognizes HLA-A2. In agreement with our findings in H9 cells, Nef had no appreciable effect on cell-surface delivery of HLA-A2 for the first 48 h postinfection in primary CD4
ϩ T-cells. Again, similar to H9 cells, at 72 h postinfection Nef markedly repressed HLA-A2 transport to the cell surface ( Figure 6B ).
To determine whether the switch in Nef-induced MHC-I down-regulation was coupled with a change in MHC-I stability, H9 cells infected with Nef Ϫ or Nef ϩ pseudotyped HIV-1 for 24 or 72 h were pulse-labeled with [
35 S]Met/Cys for 15 min and chased for up to 20 h. Immunoprecipitation of endogenous MHC-I with HC10 showed that Nef had no obvious effect on MHC-I stability at 24 or 72 h postinfection ( Figure S6 ). To assess whether Nef altered the rate of MHC-I transport, the immunoprecipitates were subjected to endoglycosidase H (Endo H) digestion, which demonstrated MHC-I molecules became Endo H resistant by 4 h postinfection irrespective of Nef expression or the time postinfection ( Figure 6C ). These findings suggest Nef does not impede MHC-I transport from early secretory pathway compartments nor does it markedly affect the stability of endogenous MHC-I molecules.
The inability of Nef to block ER-to-cell surface transport of MHC-I molecules for at least 48 h postinfection suggested that for the first two days Nef may down-regulate MHC-I by triggering the multi-kinase-dependent internalization and sequestering of MHC-I molecules from the cell surface. We tested this possibility using antibody uptake. H9 cells were infected with Nef ϩ or Nef Ϫ pseudotyped HIV-1 for 48 or 72 h and then incubated with anti-MHC-I (W6/32) in the absence or presence of 2c or PI-103. The cells were then fixed, permeabilized, and stained with a secondary antibody to detect internalized MHC-I (W6/32) and with antibody K455 to detect steady-state MHC-I ( Figure 6D ). In agreement with the biotinylation analysis, at 48 h postinfection Nef induced a marked increase in MHC-I internalization that overlapped with the MHC-I post-fix staining pattern. Treatment of the cells with 2c or PI-103 blocked antibody uptake, suggesting multi-kinase complex formation was required to down-regulate MHC-I at these time points. By contrast, at 72 h postinfection Nef failed to induce W6/32 uptake despite down-regulating MHC-I as determined by the K455 post-fix staining pattern. Analysis by flow cytometry revealed that Nef reduced cell surface levels of MHC-I to a similar extent at 48 h or 72 h postinfection ( Figure 6E ). Together, these experiments suggest that Nef-induced MHC-I down-regulation is manifest for two days by a Nefassembled PI3K signaling pathway that sequesters MHC-I endocytosed from the cell-surface followed by a switch in Nef action at day three to a stoichiometric mechanism that prevents ER to cell surface transport of newly synthesized MHC-I.
The Signaling Mode Is Required for the Switch to the Stoichiometric Mode
The switch in Nef-induced MHC-I down-regulation from a signaling-based pathway to a stoichiometric mechanism did not appear to result from use of tumor cell lines, differences in antibodies used to immunoprecipitate MHC-I, or levels of Nef expression (see Figure 6 ). We therefore asked whether the conversion of Nef-induced MHC-I down-regulation from a signaling-to a stoichiometric-mode depended upon the activity of the multi-kinase complex. To test this possibility, replicate plates of H9 cells were infected with Nef Ϫ or Nef ϩ pseudotyped HIV-1 and then treated with 2c or PI-103 at 24 or 48 h postinfection. At 72 h postinfection, the level of cell-surface MHC-I was analyzed by flow cytometry, demonstrating that addition of 2c or PI-103 for 24 or 48 h repressed the ability of Nef to down-regulate MHC-I (supplemental Figure S7 ). Next, the cells were subjected to the pulse-chase/surface biotinylation assay. In agreement with the results in Figure 6 and the flow cytometry results, Nef expressed for 72 h repressed delivery of newly synthesized MHC-I to the cell surface (Figure 7) . By contrast, treatment of the infected cells with either 2c or PI-103 for as little as 24 h before the pulse-chase/surface biotinylation prevented Nef from blocking cell-surface delivery of MHC-I (Figure 7, A and B, respectively) . Together, these results suggest that sustained PI3K signaling driven by the multikinase complex is required for Nef-induced MHC-I downregulation to switch from a signaling to a stoichiometric mode. 
DISCUSSION
We report that Nef directs a highly regulated program to down-regulate MHC-I consisting of the sequential use of the signaling and stoichiometric modes of action. During the first two days after infection, Nef uses the signaling mode to down-regulate MHC-I. This mode requires the binding of Nef to a Golgi region-localized SFK that it can directly activate to assemble a multi-kinase complex that triggers down-regulation of cell-surface MHC-I in CD4 ϩ T-cells. Using the small molecule inhibitor 2c to disrupt the Nef-SFK interaction, we repressed HIV-1 mediated down-regulation of cell-surface HLA-A2 in primary CD4
ϩ T-cells. This 2c-sensitive signaling pathway is present in primary CD4 ϩ T-cells and in H9 cells, which are replete for PTEN and are sensitive to inhibition of the multi-kinase complex. CEM cells, however, lack PTEN and thus fail to phenocopy the MHC-I down-regulation pathway used in primary CD4 ϩ T-cells. By three days postinfection, Nef switches to the stoichiometric mode that prevents delivery of newly synthesized MHC-I to the cell surface. Interference with formation of the multi-kinase complex disrupts the temporally controlled block in MHC-I transport, suggesting the Nef-directed signaling and stoichiometric modes are causally linked.
A systematic analysis of the steps underlying MHC-I down-regulation suggests 2c selectively blocks Nef action early in the down-regulation pathway at the binding of Nef to SFKs, notably Hck, Lyn, or Src (Figure 1 and supplemental Figure S3 ). However, the ability of 2c to directly inhibit Hck (or potentially other kinases upstream of class I PI3K), albeit at higher concentrations, may also contribute to the efficacy of 2c. Our NMR studies show that 2c affects the conformation of the N-terminal polyproline helix that binds the RT loop of SH3 domains on SFKs, especially V 74 ( Figure  1) . Furthermore, the NMR data identify a potential 2c binding pocket, opposite the SH3 domain binding site, in which 2c induces significant changes of the amide resonances surrounding V 146 , which has been previously identified as essential for Nef-Hck binding . Interestingly, 2c induces a change in the resonance at K 144 , which must be ubiquitylated for Nef to down-regulate CD4 (Jin et al., 2008) . The lack of effect of 2c on HIV-1-induced CD4 down-regulation (Figure 2) , however, suggests that ubiquitylation of Nef K 144 is unaffected by 2c. Together, these studies suggest 2c may be a weak competitive inhibitor of Nef-SFK binding or may induce an allosteric change in Nef that indirectly represses binding to SFKs, explaining why micromolar concentrations of 2c are required to inhibit MHC-I down-regulation. In support of an allosteric mechanism, Nef alleles from long-term nonprogressors that fail to activate Hck exhibit mutations at a distance from the Hck SH3 docking site on Nef (Trible et al., 2007) . The ability of 2c to only partially inhibit MHC-I down-regulation in plasmid transfected cells may reflect a lower efficacy of this inhibitor compared with the class I PI3K inhibitor PI-103, which completely inhibits MHC-I down-regulation irrespective of the vector used (compare Figures 2 and S7 ). However, 2c can completely inhibit Nef-mediated MHC-I down-regulation in pseudovirus-infected cells, suggesting length of treatment, as well as the extent and duration of Nef expression, may influence the efficacy of this compound. The dialdehyde moiety in 2c may also be subject to chemical inactivation by reactive oxygen species characteristic of HIV-1 infection, precluding maximal efficacy of this inhibitor (Figure 2 and supplemental Figure S2 and Peterhans, 1997) . Nonetheless, the findings reported here, together with the determination that 2c represses the Nef-Hck-dependent down-regulation of macrophage colony-stimulating factor (M-CSF) receptor and that diphenylfuropyriminde compounds that selectively block Nef-induced Hck activation also inhibit Nefdependent HIV-1 replication, suggest that the future generation of potent and selective drug-like molecules that disrupt Nef-SFK binding may represent an attractive approach to the generation of novel HIV-1 therapeutics (Suzu et al., 2005; Hiyoshi et al., 2008; Emert-Sedlak et al., 2009; Hassan et al., 2009) .
The signaling mode requires the PACS-2-dependent, Nefassembled SFK-ZAP-70/Syk-PI3K multi-kinase complex to trigger increased internalization of cell-surface MHC-I molecules through an ARF6-regulated endocytic pathway (Blagoveshchenskaya et al., 2002; Hung et al., 2007; Atkins et al., 2008; Chaudhry et al., 2008) . The internalized molecules are then sequestered into paranuclear compartments by ato disease progression. Finally, the ability of 2c and other small molecules to repress multiple actions of Nef suggests the multi-kinase complex may be an attractive approach for HIV-1 therapeutics.
